FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal

Boston Scientific (BSX.N) said on Thursday the U.S. Federal Trade Commission (FTC) has requested additional information from the medical device maker related to its $3.7 billion deal to buy Axonics (AXNX.O), opens new tab.